2022
DOI: 10.1016/s0016-5085(22)61869-9
|View full text |Cite
|
Sign up to set email alerts
|

Mo1497: PROPHYLACTIC POSTOPERATIVE IMMUNOSUPPRESSIVE THERAPY MAY REDUCE THE RISK OF POUCH FAILURE IN PATIENTS UNDERGOING INTENTIONAL ILEAL POUCH-ANAL ANASTOMOSIS FOR CROHN’S DISEASE

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Our group recently demonstrated significantly lower pouch failure rates after IPAA in patients with CD treated with prophylactic biologic therapy compared to patients who did not receive prophylaxis. 29 In addition, a recent article by Lavryk et al 30 suggested that a redo ileal pouch may be offered in cases of pouch failure in selected patients with CD, primarily because of improved medical treatment of pouch CD. In short, as the medical treatment of IBD improves, new surgical options will also develop.…”
Section: Discussionmentioning
confidence: 99%
“…Our group recently demonstrated significantly lower pouch failure rates after IPAA in patients with CD treated with prophylactic biologic therapy compared to patients who did not receive prophylaxis. 29 In addition, a recent article by Lavryk et al 30 suggested that a redo ileal pouch may be offered in cases of pouch failure in selected patients with CD, primarily because of improved medical treatment of pouch CD. In short, as the medical treatment of IBD improves, new surgical options will also develop.…”
Section: Discussionmentioning
confidence: 99%